TY - RPRT
T1 - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to sodium and potassium salts of citric acid and maintenance of normal bone (ID 330) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.
AU - EFSA Publication
AU - Tetens, Inge
PY - 2011
Y1 - 2011
N2 - Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to sodium and potassium salts of citric acid and maintenance of normal bone. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The food constituents that are the subject of the health claim are sodium and potassium salts of citric acid. The Panel considers that sodium and potassium salts of citric acid are sufficiently characterised.
The claimed effect is “acid-base balance and bone health”. The target population is assumed to be the general population. In the context of the proposed wordings, the Panel assumes that the claimed effect refers to the maintenance of normal bone by maintaining acid-base balance. The Panel considers that maintenance of normal bone is a beneficial physiological effect.
In weighing the evidence, the Panel took into account that the results from the two human intervention studies provided which investigated the effects of potassium citrate on bone mineral density in post-menopausal women are conflicting, and that the adequately powered intervention study of longer duration using a higher dose of potassium citrate did not show an effect on bone mineral density.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the dietary intake of potassium or sodium salts of citric acid and maintenance of normal bone.
AB - Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to sodium and potassium salts of citric acid and maintenance of normal bone. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The food constituents that are the subject of the health claim are sodium and potassium salts of citric acid. The Panel considers that sodium and potassium salts of citric acid are sufficiently characterised.
The claimed effect is “acid-base balance and bone health”. The target population is assumed to be the general population. In the context of the proposed wordings, the Panel assumes that the claimed effect refers to the maintenance of normal bone by maintaining acid-base balance. The Panel considers that maintenance of normal bone is a beneficial physiological effect.
In weighing the evidence, the Panel took into account that the results from the two human intervention studies provided which investigated the effects of potassium citrate on bone mineral density in post-menopausal women are conflicting, and that the adequately powered intervention study of longer duration using a higher dose of potassium citrate did not show an effect on bone mineral density.
On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the dietary intake of potassium or sodium salts of citric acid and maintenance of normal bone.
U2 - 10.2903/j.efsa.2011.2302
DO - 10.2903/j.efsa.2011.2302
M3 - Report
T3 - the EFSA Journal
BT - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to sodium and potassium salts of citric acid and maintenance of normal bone (ID 330) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.
PB - European Food Safety Authority
CY - Parma, Italy
ER -
